Icon

PREVDUO (NDA216903)- (0.6MG/3ML (0.2MG/ML);3MG/3ML (1MG/ML))

GLYCOPYRROLATE; NEOSTIGMINE METHYLSULFATE AZURITY
0.6MG/3ML (0.2MG/ML);3MG/3ML (1MG/ML)
No Yes
2038-Oct-25 Expired
None None
None No
PREVDUO, a fixed dose combination of a cholinesterase inhibitor and antimuscarinic agent, is indicated in patients age two years and above for the reversal of the effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery, while decreasing the peripheral muscarinic effects (e.g., bradycardia and excessive secretions) associated with cholinesterase inhibition following NMBA reversal administration.
0 0 0
Total Other Developers None
Drugs with Suitability No
0.6MG/3ML (0.2MG/ML);3MG/3ML (1MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.